Evidence map›Paper›PMID 34269536›Full record

ArticleKorean journal of radiology2021

Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.

Elena Pak, Kyu Sung Choi, Seung Hong Choi, Chul-Kee Park, Tae Min Kim, Sung-Hye Park, Joo Ho Lee, Soon-Tae Lee, Inpyeong Hwang, Roh-Eul Yoo and 4 more

Abstract read
In one paragraph

Article in Korean journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Elena Pak *Department of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-2304-2188
Kyu Sung Choi *Department of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-5175-3307
Seung Hong ChoiDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-0412-2270
Chul-Kee ParkDepartment of Neurosurgery and Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-2350-9876
Tae Min KimDepartment of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-6145-4426
Sung-Hye ParkDepartment of Pathology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-8681-1597
Joo Ho LeeDepartment of Radiation Oncology, Cancer Research Institute, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-7248-3214
Soon-Tae LeeDepartment of Neurology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0003-4767-7564
Inpyeong HwangDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-1291-8973
Roh-Eul YooDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-5625-5921
Koung Mi KangDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-9643-2008
Tae Jin YunDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0001-8441-4574
Ji-Hoon KimDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-6349-6950
Chul-Ho SohnDepartment of Radiology, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0003-0039-5746

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop a radiomics risk score based on dynamic contrast-enhanced (DCE) MRI for prognosis prediction in patients with glioblastoma. MATERIALS AND

methodsOne hundred and fifty patients (92 male [61.3%]; mean age ± standard deviation, 60.5 ± 13.5 years) with glioblastoma who underwent preoperative MRI were enrolled in the study. Six hundred and forty-two radiomic features were extracted from volume transfer constant (K

results16 radiomic features obtained from non-enhancing T2 hyperintense areas were selected among the 642 features identified. The radiomics risk score was used to stratify high- and low-risk groups in both the discovery and validation sets (both

conclusionWe developed and validated the "radiomics risk score" from the features of DCE MRI based on non-enhancing T2 hyperintense areas for risk stratification of patients with glioblastoma. It was associated with progression-free survival independently of IDH mutation status.

Indexed as

Brain NeoplasmsGlioblastomaAgedHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMaleMiddle AgedPrognosisRetrospective StudiesIsocitrate DehydrogenaseDynamic contrast enhanced MRIGlioblastomaKProgressionRadiomicsV

Identifiers

PMID34269536
PMCPMC8390822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.